Lv51
1500 积分 2023-03-28 加入
Primary de novo Epidermal Growth Factor Receptor Mutant Small Cell Lung Carcinomas: Clinicopathological Study of a Rare Entity Presenting in Treatment-Naïve Setting with Review of Literature
5小时前
待确认
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
23天前
已完结
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
23天前
已完结
Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib
23天前
已完结
Surufatinib: First Approval
24天前
已完结
The biological and technical challenges facing utilizing circulating tumor DNA in non-metastatic breast cancer patients
25天前
已完结
Correction: Clinical Significance of PIK3CA and ESR1 Mutations in Circulating Tumor DNA: Analysis from the MONARCH 2 Study of Abemaciclib plus Fulvestrant
26天前
已完结
Genomic and fragmentomic landscapes of cell-free DNA for early cancer detection
26天前
已完结
522 Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
1个月前
已完结
皖公网安备34019202002308
